Moderna inks agreement with Resilience to manufacture mRNA for Covid-19 vaccine
National Resilience, (Resilience), a company seeking to build the world's most advanced biopharmaceutical manufacturing ecosystem, and Moderna announced an agreement to manufacture drug substance for the Moderna Covid-19 vaccine
MRNA For Covid-19 Vaccine | 13/09/2021 | By Darshana | 191
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy